Home/Filings/4/0001567619-20-001989
4//SEC Filing

Vincent Mark D. 4

Accession 0001567619-20-001989

CIK 0000882361other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 9:52 PM ET

Size

5.9 KB

Accession

0001567619-20-001989

Insider Transaction Report

Form 4
Period: 2020-01-31
Transactions
  • Award

    Director Option Grant

    2020-01-31+154,000154,000 total
    Exercise: $6.91Exp: 2030-01-30Common Shares (154,000 underlying)
Footnotes (2)
  • [F1]Converted from Canadian exercise price of C$9.10 using an exchange rate of 1.3169.
  • [F2]Fifty percent (50%) of the options vest on 1/31/2021. The remaining 50% vest as follows: one-half on 1/31/2022 and one-half on 1/31/2023.

Documents

1 file

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001761243

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 9:52 PM ET
Size
5.9 KB